Table 1 Relationship between TCTP expression and clinical features of HCC patients.
Clinical features | Number | TCTP overexpression (%) | P value |
|---|---|---|---|
Gender | 0.721 | ||
Female | 35 | 27 (77.2) | |
Male | 14 | 10 (71.4) | |
Age (years) | 1.254 | ||
≤60 | 35 | 26 (74.3) | |
>60 | 14 | 11 (75.6) | |
HBsAg | 1.548 | ||
Positive | 38 | 27 (71.1) | |
Negative | 11 | 8 (72.7) | |
Serum AFP (ng/ml) | 0.754 | ||
≤400 | 19 | 13 (68.4) | |
>400 | 30 | 22 (73.3) | |
Tumor size (cm) | 0.183 | ||
≤5 | 23 | 15 (65.2) | |
>5 | 26 | 22 (84.6) | |
Pathological grades | 0.019 | ||
Ι | 4 | 2 (50.0) | |
II | 33 | 22 (66.7) | |
III | 12 | 11 (91.7) | |
TNM stage | 0.006 | ||
Ι–III | 38 | 28 (73.7) | |
IV | 11 | 7 (63.6) | |
Tumor stage (AJCC) | 0.49 | ||
Stage Ι | 7 | 5 (71.4) | |
Stage II | 32 | 23 (71.9) | |
Stage III | 10 | 9 (90.0) | |
